BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Dietary fucoidan of Acaudina molpadioides alters gut microbiota and mitigates intestinal mucosal injury induced by cyclophosphamide. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 8 Issue 9 Pages: 3383-3393 Pub: 2017 Sep 20 Epub: Authors Shi H , Chang Y , Gao Y , Wang X , Chen X , Wang Y , Xue C , Tang Q , |
|
|
Fucoidan Improves D-Galactose-Induced Cognitive Dysfunction by Promoting Mitochondrial Biogenesis and Maintaining Gut Microbiome Homeostasis. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 10 Pages: Pub: 2024 May 17 Epub: 2024 May 17 Authors Xu Y , Xue M , Li J , Ma Y , Wang Y , Zhang H , Liang H , |
|
|
Fucoidan Improves D-Galactose-Induced Cognitive Dysfunction by Promoting Mitochondrial Biogenesis and Maintaining Gut Microbiome Homeostasis. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 10 Pages: Pub: 2024 May 17 Epub: 2024 May 17 Authors Xu Y , Xue M , Li J , Ma Y , Wang Y , Zhang H , Liang H , |
|
|
Anti-obesity effects of Laminaria japonica fucoidan in high-fat diet-fed mice vary with the gut microbiota structure. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 13 Issue 11 Pages: 6259-6270 Pub: 2022 Jun 6 Epub: 2022 Jun 6 Authors Zhang X , You Y , Wang L , Ai C , Huang L , Wang S , Wang Z , Song S , Zhu B , |
|
|
Laminaria japonica Polysaccharide Regulates Fatty Hepatosis Through Bile Acids and Gut Microbiota in Diabetes Rat. ✅
Go to Publication ✅
Marine biotechnology (New York, N.Y.) (Mar Biotechnol (NY) ) Vol: Issue Pages: Pub: 2024 Aug 29 Epub: 2024 Aug 29 Authors Zhang B , Wang J , Chen X , Xue T , Xin J , Liu Y , Wang X , Li X , |
|
|
Laminaria japonica Polysaccharide Regulates Fatty Hepatosis Through Bile Acids and Gut Microbiota in Diabetes Rat. ✅
Go to Publication ✅
Marine biotechnology (New York, N.Y.) (Mar Biotechnol (NY) ) Vol: Issue Pages: Pub: 2024 Aug 29 Epub: 2024 Aug 29 Authors Zhang B , Wang J , Chen X , Xue T , Xin J , Liu Y , Wang X , Li X , |
|
|
Fucoidan modulates gut microbiota and immunity in Peyer's patches against inflammatory bowel disease. ✅
Go to Publication ✅
Carbohydrate polymers (Carbohydr Polym ) Vol: 342 Issue Pages: 122421 Pub: 2024 Oct 15 Epub: 2024 Jun 19 Authors Li JK , Veeraperumal S , Aweya JJ , Liu Y , Cheong KL , |
|
|
Fucoidan modulates gut microbiota and immunity in Peyer's patches against inflammatory bowel disease. ✅
Go to Publication ✅
Carbohydrate polymers (Carbohydr Polym ) Vol: 342 Issue Pages: 122421 Pub: 2024 Oct 15 Epub: 2024 Jun 19 Authors Li JK , Veeraperumal S , Aweya JJ , Liu Y , Cheong KL , |
|
|
High-molecular-weight Fucoidan exerts an immune-enhancing effect in RAW 264.7 cells and cyclophosphamide-induced immunosuppression rat by altering the gut microbiome. ✅
Go to Publication ✅
International immunopharmacology (Int Immunopharmacol ) Vol: 139 Issue Pages: 112677 Pub: 2024 Sep 30 Epub: 2024 Jul 17 Authors Park EJ , Kim JY , Jaiswal V , Park HS , Ki DB , Lee YS , Lee HJ , |
|
|
Therapeutic Potential of Fucoidan in Alleviating Histamine-Induced Liver Injury: Insights from Mice Studies. ✅
Go to Publication ✅
Foods (Basel, Switzerland) (Foods ) Vol: 13 Issue 10 Pages: Pub: 2024 May 14 Epub: 2024 May 14 Authors Zhang M , Liu H , Xu L , Zhang X , Chen W , Wang C , |
|
|
Fucoidan alleviated dextran sulfate sodium-induced ulcerative colitis with improved intestinal barrier, reshaped gut microbiota composition, and promoted autophagy in male C57BL/6 mice. ✅
Go to Publication ✅
Nutrition research (New York, N.Y.) (Nutr Res ) Vol: 122 Issue Pages: 1-18 Pub: 2024 Feb Epub: 2023 Nov 17 Authors Li S , Qian Q , Yang H , Wu Z , Xie Y , Yin Y , Cui Y , Li X , |
|
|
Fucoidan alleviated dextran sulfate sodium-induced ulcerative colitis with improved intestinal barrier, reshaped gut microbiota composition, and promoted autophagy in male C57BL/6 mice. ✅
Go to Publication ✅
Nutrition research (New York, N.Y.) (Nutr Res ) Vol: 122 Issue Pages: 1-18 Pub: 2024 Feb Epub: 2023 Nov 17 Authors Li S , Qian Q , Yang H , Wu Z , Xie Y , Yin Y , Cui Y , Li X , |
|
|
Bioactive polysaccharides promote gut immunity via different ways. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 14 Issue 3 Pages: 1387-1400 Pub: 2023 Feb 6 Epub: 2023 Feb 6 Authors Wu X , Huang X , Ma W , Li M , Wen J , Chen C , Liu L , Nie S , |
|
|
Bioactive polysaccharides promote gut immunity via different ways. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 14 Issue 3 Pages: 1387-1400 Pub: 2023 Feb 6 Epub: 2023 Feb 6 Authors Wu X , Huang X , Ma W , Li M , Wen J , Chen C , Liu L , Nie S , |
|
|
Fucoidan from Scytosiphon lomentaria protects against destruction of intestinal barrier, inflammation and lipid abnormality by modulating the gut microbiota in dietary fibers-deficient mice. ✅
Go to Publication ✅
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 224 Issue Pages: 556-567 Pub: 2023 Jan 1 Epub: 2022 Oct 19 Authors Jia J , Zheng W , Zhang C , Zhang P , Guo X , Song S , Ai C , |
|
|
A fucoidan from sea cucumber Pearsonothuria graeffei with well-repeated structure alleviates gut microbiota dysbiosis and metabolic syndromes in HFD-fed mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 9 Issue 10 Pages: 5371-5380 Pub: 2018 Oct 17 Epub: Authors Li S , Li J , Mao G , Wu T , Hu Y , Ye X , Tian D , Linhardt RJ , Chen S , |
|
|
A fucoidan from sea cucumber Pearsonothuria graeffei with well-repeated structure alleviates gut microbiota dysbiosis and metabolic syndromes in HFD-fed mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 9 Issue 10 Pages: 5371-5380 Pub: 2018 Oct 17 Epub: Authors Li S , Li J , Mao G , Wu T , Hu Y , Ye X , Tian D , Linhardt RJ , Chen S , |
|
|
A fucoidan from sea cucumber Pearsonothuria graeffei with well-repeated structure alleviates gut microbiota dysbiosis and metabolic syndromes in HFD-fed mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 9 Issue 10 Pages: 5371-5380 Pub: 2018 Oct 17 Epub: Authors Li S , Li J , Mao G , Wu T , Hu Y , Ye X , Tian D , Linhardt RJ , Chen S , |
|
|
Fucoidan from Undaria pinnatifida Enhances Exercise Performance and Increases the Abundance of Beneficial Gut Bacteria in Mice. ✅
Go to Publication ✅
Marine drugs (Mar Drugs ) Vol: 22 Issue 11 Pages: Pub: 2024 Oct 29 Epub: 2024 Oct 29 Authors Yang C , Dwan C , Wimmer BC , Wilson R , Johnson L , Caruso V , |
|
|
Fucoidan from Undaria pinnatifida Enhances Exercise Performance and Increases the Abundance of Beneficial Gut Bacteria in Mice. ✅
Go to Publication ✅
Marine drugs (Mar Drugs ) Vol: 22 Issue 11 Pages: Pub: 2024 Oct 29 Epub: 2024 Oct 29 Authors Yang C , Dwan C , Wimmer BC , Wilson R , Johnson L , Caruso V , |
|
|
Low molecular fucoidan alleviated alcohol-induced liver injury in BALB/c mice by regulating the gut microbiota-bile acid-liver axis. ✅
Go to Publication ✅
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 282 Issue Pt 3 Pages: 136930 Pub: 2024 Dec Epub: 2024 Oct 28 Authors Sun Y , Men Q , Ren X , Yan C , Song S , Ai C , |
|
|
A low molecular weight fucoidan with high sulfation has anti-obesity activity via gut microbiota regulation. ✅
Go to Publication ✅
Carbohydrate polymers (Carbohydr Polym ) Vol: 364 Issue Pages: 123739 Pub: 2025 Sep 15 Epub: 2025 May 15 Authors Yu Y , Zhao Y , Wang H , Hua Y , Yu W , Wang N , Wei B , Wang H , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
